Domestic pharma growth rebounds for the month of April

The domestic pharma industry staged a rebound in growth for the month of April. According to data compiled by PharmaTrac, at 9.7%, the growth is better than the 6% and 7.7% growth witnessed in the preceding two months and is tad lower than the 9.8% seen in January.

There was an improvement of growth in case of the anti-infectives segment, being the largest category in the Indian pharmaceutical market constituting nearly 18% of the industry revenues. The segment which grew by merely 2% grew 6%. Other major categories like cardiac, gastro intestinal, vitamins and respiratory grew in the range of 8 to 10% for the month of April.

Amongst the top 10 companies, the Zydus (Cadila Healthcare group) grew at 28%, Sun Pharma at 26% and Alkem grew at 17%.